171 related articles for article (PubMed ID: 37358927)
1. What are the predominant predictors of seizure relapse following discontinuation of anti-seizure medication in epileptic children?
Kanmaz S; Toprak DE; Olculu CB; Dokurel I; Simsek E; Serin HM; Yılmaz S; Aktan G; Gokben S; Tekgul H
Epileptic Disord; 2023 Apr; 25(2):218-228. PubMed ID: 37358927
[TBL] [Abstract][Full Text] [Related]
2. Risk of seizure relapse and long-term outcomes after discontinuation of antiseizure medication in children with epilepsy.
Yıldırım M; Bektaş Ö; Kartal AT; Yeniay Süt N; Teber S
Epilepsy Behav; 2022 Sep; 134():108779. PubMed ID: 35763995
[TBL] [Abstract][Full Text] [Related]
3. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.
Strozzi I; Nolan SJ; Sperling MR; Wingerchuk DM; Sirven J
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD001902. PubMed ID: 25922863
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of persistent interictal epileptiform discharges on antiseizure medication withdrawal in patients with epilepsy in five-year remission.
Liang X; Yu N; Zhang YF; Gu L; Di Q
Seizure; 2022 Jan; 94():100-106. PubMed ID: 34883461
[TBL] [Abstract][Full Text] [Related]
5. Rapid versus slow withdrawal of antiepileptic drugs.
Ayuga Loro F; Gisbert Tijeras E; Brigo F
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD005003. PubMed ID: 35005782
[TBL] [Abstract][Full Text] [Related]
6. Non-discontinuation of antiseizure medication in seizure-free epilepsy patients.
Doerrfuss JI; Hüsing T; Graf L; Ilyas-Feldmann M; Holtkamp M
Eur J Neurol; 2024 Mar; 31(3):e16160. PubMed ID: 38015451
[TBL] [Abstract][Full Text] [Related]
7. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
Nolan SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD001904. PubMed ID: 27976799
[TBL] [Abstract][Full Text] [Related]
8. Early antiseizure medication withdrawal and risk of seizure recurrence in children after epilepsy surgery: A retrospective study.
Wu Y; Zhang Z; Liang P; Zou B; Wang D; Wu X; Zhai X
Epilepsy Behav; 2024 Jan; 150():109556. PubMed ID: 38029661
[TBL] [Abstract][Full Text] [Related]
9. Two-year remission and subsequent relapse in children with newly diagnosed epilepsy.
Berg AT; Shinnar S; Levy SR; Testa FM; Smith-Rapaport S; Beckerman B; Ebrahimi N
Epilepsia; 2001 Dec; 42(12):1553-62. PubMed ID: 11879366
[TBL] [Abstract][Full Text] [Related]
10. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
Nolan SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2015 Jul; (7):CD001904. PubMed ID: 26204241
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of the second withdrawal of anti-seizure medication in patients with pediatric-onset epilepsy.
Cho J; Kim H; Chae JH; Kim KJ; Lim BC
Epilepsia; 2023 Jun; 64(6):e93-e97. PubMed ID: 36976527
[TBL] [Abstract][Full Text] [Related]
12. Recurrence rates and risk factors for seizure recurrence following antiseizure medication withdrawal in adolescent patients with genetic generalized epilepsy.
Komatsubara T; Kobayashi Y; Hiraiwa A; Magara S; Hojo M; Ono T; Okazaki K; Fukuda M; Tohyama J
Epilepsia Open; 2022 Jun; 7(2):332-343. PubMed ID: 35445562
[TBL] [Abstract][Full Text] [Related]
13. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001904. PubMed ID: 30353945
[TBL] [Abstract][Full Text] [Related]
14. Oligoepilepsy and lifelong seizure susceptibility in epilepsy with generalized tonic-clonic seizures alone: Experience at an adult tertiary center.
Peña-Ceballos J; Moloney PB; Kilbride RD; Naggar HE; Widdess-Walsh P; Delanty N
Epilepsy Res; 2024 May; 202():107362. PubMed ID: 38652996
[TBL] [Abstract][Full Text] [Related]
15. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nolan SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2015 Aug; (8):CD001911. PubMed ID: 26275105
[TBL] [Abstract][Full Text] [Related]
16. Antiepileptic drug withdrawal in childhood epilepsy: what are the risk factors associated with seizure relapse?
Verrotti A; D'Egidio C; Agostinelli S; Parisi P; Spalice A; Chiarelli F; Coppola G
Eur J Paediatr Neurol; 2012 Nov; 16(6):599-604. PubMed ID: 22398177
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Long-Term Outcomes of Monotherapy and Polytherapy in Seizure-Free Patients With Epilepsy Following Antiseizure Medication Withdrawal.
Wang Y; Xia L; Li R; Li Y; Li J; Zhou Q; Pan S
Front Neurol; 2021; 12():669703. PubMed ID: 34108931
[No Abstract] [Full Text] [Related]
18. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001911. PubMed ID: 28240353
[TBL] [Abstract][Full Text] [Related]
19. Video-EEG-monitoring to guide antiseizure medication withdrawal.
Dhaenens-Meyer LKL; Schriewer E; Weber YG; Wolking S
Neurol Res Pract; 2023 May; 5(1):20. PubMed ID: 37198666
[TBL] [Abstract][Full Text] [Related]
20. Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis.
Lamberink HJ; Otte WM; Geerts AT; Pavlovic M; Ramos-Lizana J; Marson AG; Overweg J; Sauma L; Specchio LM; Tennison M; Cardoso TMO; Shinnar S; Schmidt D; Geleijns K; Braun KPJ
Lancet Neurol; 2017 Jul; 16(7):523-531. PubMed ID: 28483337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]